(Q37364508)

19 August 2017

Mucopolysaccharidosis VI: the Italian experience (English)

1 reference

19 August 2017

0 references

mucopolysaccharidosis VI

1 reference

2

0 references

Rossella Parini

object named as

Rossella Parini

9

0 references

author name string

Maurizio Scarpa

1

1 reference

19 August 2017

Agata Fiumara

3

1 reference

19 August 2017

Luca Astarita

4

1 reference

19 August 2017

Giancarlo Parenti

5

1 reference

19 August 2017

Angelica Rampazzo

6

1 reference

19 August 2017

Stefania Sala

7

1 reference

19 August 2017

Giovanni Sorge

8

1 reference

19 August 2017

7 January 2009

1 reference

European Journal of Pediatrics

19 August 2017

1 reference

19 August 2017

168

1 reference

19 August 2017

10

1 reference

19 August 2017

1203-1206

1 reference

https://scigraph.springernature.com/pub.10.1007/s00431-008-0910-z

19 August 2017

0 references

cites work

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

1 reference

12 December 2020

Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.

1 reference

12 December 2020

Management guidelines for mucopolysaccharidosis VI.

1 reference

12 December 2020

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

1 reference

12 December 2020

Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI

1 reference

12 December 2020

Replacement therapy in Mucopolysaccharidosis type VI: advantages of early onset of therapy.

1 reference

12 December 2020

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

1 reference

12 December 2020

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

1 reference

12 December 2020

10.1007/S00431-008-0910-Z

Identifiers

DOI

1 reference

19 August 2017

1 reference